Jan 17, 2023, 10:28 AM by

Tune Therapeutics, a biotechnology company pioneering the creation of genetic tuning (epigenomic editing) therapies, today announced the addition of John McHutchison AO, MD – former CEO at Assembly Biosciences, Inc., and CSO at Gilead Sciences, Inc. – to its board of directors.

Jan 17, 2023, 10:25 AM by

Jan 17, 2023, 10:24 AM by

Jan 17, 2023, 10:23 AM by

OncoDxRx’s one-of-a-kind liquid biopsy PGA platform is a breakthrough backed by comprehensive profiling of cancer pathways and anti-cancer drugs.

Jan 17, 2023, 01:00 AM by User Not Found

Bio-IT World | In a paper published late last year in Nature Communications, researchers from Penn Medicine and Intel Labs report on what they call the largest to-date global federated learning effort to develop an accurate and generalizable machine learning model for detecting glioblastoma borders. The work has important implications both clinically and as a model for future large, federated learning projects.

Jan 16, 2023, 10:25 AM by

Jan 16, 2023, 10:21 AM by

Jan 16, 2023, 10:17 AM by

Jan 16, 2023, 10:16 AM by

Jan 16, 2023, 10:15 AM by

FAIRE grants provide access to the Cambridge Structural Database, software and training. The Frank H. Allen International Research & Education Programme (FAIRE) provides long-term grants to enable academic research in structural chemistry in over 80 eligible countries. Launched in 2017, the number of research and educational institutions with a FAIRE license nearly doubled in 2022 to 31. The initiative has supported researchers to publish over 100 scientific publications in primary research journals since its launch. With research and education organisations in over 80 countries eligible to apply, the FAIRE programme has the potential to greatly widen its positive impact and new applications are welcomed. Continued engagement with the structural science community through conferences like the Pan African Conference on Crystallography (PCCr3) currently being held in Nairobi, Kenya, aims to grow and further support the FAIRE community.

Jan 13, 2023, 10:10 AM by

With SmartRenewal, DrFirst Takes Aim at the Dangers of Entering Medication Renewals by Hand

Jan 13, 2023, 09:07 AM by User Not Found

Bio-IT World | In his second J.P. Morgan Healthcare Conference address on behalf of Pacific Biosystems, CEO Christian Henry gave a summary of 2022 numbers and updates on the new sequencing platforms the company announced in October: the Revio long-read platform and the Onso short-read platform.

Jan 13, 2023, 01:00 AM by User Not Found

Bio-IT World | In BioPharma, development to manufacturing often feel as if they are separated by an invisible wall. While the enterprise may be joint, development and manufacturing cultures are distinct. Poor information sharing can make findings feel like closely guarded secrets. This siloed approach was the accepted norm in earlier eras. Now, it is due for a major renovation.

Jan 12, 2023, 09:53 AM by

Jan 12, 2023, 09:12 AM by User Not Found

Bio-IT World | Illumina President and CEO Francis deSouza kicked off his annual J.P. Morgan Healthcare Conference presentation highlighting the breadth of the genomics market. deSouza sees a $120 billion total addressable market for Illumina, with oncology testing representing more than half of the opportunity.

Jan 11, 2023, 10:58 AM by

Jan 11, 2023, 10:57 AM by

Argonaut Manufacturing Services Set to Expand Drug Product Fill/Finish Capabilities with Significant Capital Investment

Jan 11, 2023, 01:00 AM by User Not Found

Bio-IT World | Serge Saxonov, CEO and co-founder of 10x Genomics, kicked off Monday’s sessions at the 41st annual J.P. Morgan Healthcare Conference with an overview of the company’s overall progress in its Visium, Chromium, and Xenium platforms. Instead of delving too deeply in specific product announcements, Saxonov emphasized the strength of the 10x team, the mergers and acquisitions that have led to the development of the platforms, and the breadth of the company offerings.

Jan 10, 2023, 11:31 AM by

CSafe Connect enables a truly connected supply chain by bringing together product ordering, shipment analytics and customer support under a single login

Jan 10, 2023, 11:31 AM by

Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark. London, UK and Durham, NC – January 10, 2023 – Phastar announced today the acquisition of S-Cubed ApS, a specialist biometrics and data visualization company. The deal takes the PHASTAR group to around 550 people worldwide and strengthens the company's position in the Nordic region.